News

Researchers found that the bug can retain human DNA in their guts for up to 45 days after feeding. Read more at ...
LCGC International interviewed Professor Torgny Fornstedt, Head of the Fundamental Separation Science Group at Karlstad ...
From the time we are conceived and through old age, genetic mutations accumulate in all our tissues, eluding the body's ...
The Synthetic Human Genome, or Syn HG, a project launched on June 26th, aims to change that. Funded partly by Wellcome, a ...
The sensitive identification of single nucleotide polymorphisms becomes increasingly important for disease diagnosis, prevention, and practical applicability of pharmacogenomics. Herein, we propose a ...
A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.
VAV1 is a guanine nucleotide exchange factor essential for T- and B-cell receptor signaling, with expression largely restricted to immune cells. Loss of VAV1, via CRISPR or genetic deletion, impairs ...
Organ transplantation has significantly revolutionized the treatment of patients with organ failure. However, the recipient's ...
For the first time, the extreme variability in dengue fever has been linked to a biological mechanism, potentially opening ...
ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCPFirst-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy ...
The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).